Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Armstrong, PW; Adams, PX; Al-Khalidi, HR; Hamm, C; Holmes, D; O'Neill, W; Todaro, TG; Vahanian, A; Van de Werf, F; Granger, CB; APEX-AMI Steering Committee,

Published Date

  • March 2005

Published In

Volume / Issue

  • 149 / 3

Start / End Page

  • 402 - 407

PubMed ID

  • 15864228

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2004.12.015


  • eng

Conference Location

  • United States